Kalbe Farma Tbk PT (KLBF)

Jakarta
Currency in IDR
1,050
-35(-3.23%)
Closed
KLBF Scorecard
Full Analysis
Stock has taken a big hit over the last week
Trading near 52-week Low
Fair Value
Day's Range
1,0401,085
52 wk Range
1,0401,795
Key Statistics
Edit
Bid/Ask
1,045.00 / 1,055.00
Prev. Close
1,085
Open
1,085
Day's Range
1,040-1,085
52 wk Range
1,040-1,795
Volume
38.55M
Average Volume (3m)
39.53M
1-Year Change
-26.83%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KLBF Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,679
Upside
+59.86%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Kalbe Farma Tbk PT Company Profile

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Employees
12924
Market
Indonesia

Compare KLBF to Peers and Sector

Metrics to compare
KLBF
Peers
Sector
Relationship
P/E Ratio
15.7x18.1x−0.5x
PEG Ratio
3.210.000.00
Price/Book
2.2x2.1x2.6x
Price / LTM Sales
1.5x1.4x3.0x
Upside (Analyst Target)
58.1%15.4%56.3%
Fair Value Upside
Unlock24.1%10.0%Unlock

Analyst Ratings

11 Buy
2 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,679
(+59.86% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 66.79
Dividend Yield
2.86%
Industry Median 7.22%
Annualized payout
31.00
Paid annually
5-Years Growth
+3.58%
Growth Streak

Earnings

Latest Release
Oct 30, 2024
EPS / Forecast
12.32 / 14.93
Revenue / Forecast
7.911T / 7.911T
EPS Revisions
Last 90 days

People Also Watch

22,725
UNTR
-1.41%
23,125
ITMG
-1.18%

FAQ

What Is the Kalbe Farma (KLBF) Stock Price Today?

The Kalbe Farma stock price today is 1,050.00

What Stock Exchange Does Kalbe Farma Trade On?

Kalbe Farma is listed and trades on the Jakarta stock exchange.

What Is the Stock Symbol for Kalbe Farma?

The stock symbol for Kalbe Farma is "KLBF."

Does Kalbe Farma Pay Dividends? What’s The Current Dividend Yield?

The Kalbe Farma dividend yield is 2.95%.

What Is the Kalbe Farma Market Cap?

As of today, Kalbe Farma market cap is 48.46T.

What is Kalbe Farma Earnings Per Share?

The Kalbe Farma EPS is 66.79.

What Is the Next Kalbe Farma Earnings Date?

Kalbe Farma will release its next earnings report on Mar 27, 2025.

From a Technical Analysis Perspective, Is KLBF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.